X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs SUVEN LIFESCIENCES - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON SUVEN LIFESCIENCES BIOCON /
SUVEN LIFESCIENCES
 
P/E (TTM) x 40.9 21.5 190.3% View Chart
P/BV x 7.1 4.1 175.4% View Chart
Dividend Yield % 0.2 0.6 28.9%  

Financials

 BIOCON    SUVEN LIFESCIENCES
EQUITY SHARE DATA
    BIOCON
Mar-18
SUVEN LIFESCIENCES
Mar-18
BIOCON /
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs1,188251 473.7%   
Low Rs305155 196.8%   
Sales per share (Unadj.) Rs68.749.1 139.9%  
Earnings per share (Unadj.) Rs7.69.7 77.7%  
Cash flow per share (Unadj.) Rs14.011.4 122.6%  
Dividends per share (Unadj.) Rs1.001.50 66.7%  
Dividend yield (eoy) %0.10.7 18.1%  
Book value per share (Unadj.) Rs86.360.3 143.2%  
Shares outstanding (eoy) m600.00127.28 471.4%   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x10.94.1 263.0%   
Avg P/E ratio x98.920.9 473.4%  
P/CF ratio (eoy) x53.417.8 300.0%  
Price / Book Value ratio x8.63.4 256.9%  
Dividend payout %13.215.4 85.8%   
Avg Mkt Cap Rs m447,90025,825 1,734.4%   
No. of employees `0006.11.1 573.6%   
Total wages/salary Rs m9,311613 1,519.7%   
Avg. sales/employee Rs Th6,705.85,832.6 115.0%   
Avg. wages/employee Rs Th1,514.2571.5 264.9%   
Avg. net profit/employee Rs Th736.91,153.8 63.9%   
INCOME DATA
Net Sales Rs m41,2346,253 659.5%  
Other income Rs m2,062233 886.1%   
Total revenues Rs m43,2966,485 667.6%   
Gross profit Rs m8,2911,982 418.4%  
Depreciation Rs m3,851213 1,807.1%   
Interest Rs m61546 1,328.3%   
Profit before tax Rs m5,8871,955 301.1%   
Minority Interest Rs m2130-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,569718 218.4%   
Profit after tax Rs m4,5311,237 366.3%  
Gross profit margin %20.131.7 63.4%  
Effective tax rate %26.736.7 72.5%   
Net profit margin %11.019.8 55.5%  
BALANCE SHEET DATA
Current assets Rs m41,4865,622 737.9%   
Current liabilities Rs m21,4131,168 1,833.9%   
Net working cap to sales %48.771.2 68.3%  
Current ratio x1.94.8 40.2%  
Inventory Days Days6481 78.6%  
Debtors Days Days9436 262.1%  
Net fixed assets Rs m50,6613,325 1,523.8%   
Share capital Rs m3,000127 2,356.6%   
"Free" reserves Rs m48,8087,547 646.7%   
Net worth Rs m51,8087,674 675.1%   
Long term debt Rs m17,89814 128,762.6%   
Total assets Rs m99,8979,135 1,093.5%  
Interest coverage x10.643.2 24.5%   
Debt to equity ratio x0.30 19,073.1%  
Sales to assets ratio x0.40.7 60.3%   
Return on assets %5.214.0 36.7%  
Return on equity %8.716.1 54.3%  
Return on capital %9.626.0 37.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,0585,066 238.0%   
Fx outflow Rs m7,3482,001 367.2%   
Net fx Rs m4,7103,065 153.7%   
CASH FLOW
From Operations Rs m6,621699 946.7%  
From Investments Rs m-6,840-6 112,131.1%  
From Financial Activity Rs m-2,397-577 415.4%  
Net Cashflow Rs m-2,612116 -2,245.9%  

Share Holding

Indian Promoters % 40.4 63.4 63.7%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 0.0 -  
FIIs % 10.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 19.9 36.5 54.5%  
Shareholders   109,995 37,287 295.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   PANACEA BIOTECH  DISHMAN PHARMA  FULFORD INDIA  NATCO PHARMA  AJANTA PHARMA  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 490 Points Higher; Oil & Gas and Telecom Stocks Witness Buying(Closing)

Indian share markets continued to witness buying interest and ended their trading session on a positive note. Gains were largely seen in the oil & gas sector.

Related Views on News

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

SUVEN LIFE Announces Quarterly Results (2QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, SUVEN LIFE has posted a net profit of Rs 180 m (down 43.3% YoY). Sales on the other hand came in at Rs 895 m (down 16.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

SUVEN LIFE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 14, 2018 | Updated on Aug 14, 2018

Here's an analysis of the annual report of SUVEN LIFE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFE. Also includes updates on the valuation of SUVEN LIFE.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

A Simple 3-Point Investing Manifesto for You the Indian Investor(The 5 Minute Wrapup)

Apr 11, 2019

A must have checklist for every investor in the Indian stock market.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Apr 24, 2019 (Close)

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS